CDC: Pfizer, Moderna boosters prevent Omicron hospitalizations - Breaking The News

CDC: Pfizer, Moderna boosters prevent Omicron hospitalizations

21 January

1 min read

EPA-EFE/ERIK S. LESSER

The United States Centers for Disease Control and Prevention (CDC) remarked on Friday that the booster shots of the vaccines against COVID-19 produced by Pfizer Inc. and BioNTech SE and Moderna Inc. showed high efficiency in preventing hospitalizations from the Omicron strain of the virus.

The agency added the aforementioned boosters proved to be 90% effective in protecting those infected with Omicron from being hospitalized. They also seem to reduce the possibility of visiting health institutions for help. The CDC added those doses were particularly successful in preventing deaths linked to Omicron in people aged 50 and over.

The news comes shortly after Pfizer Chief Executive Officer (CEO) Albert Bourla stated the company expects to have a vaccine aimed specifically at protecting from Omicron in March.

coronavirus cdc coronavirus vaccine pfizer biontech moderna

Related Stocks

BioNTech

Pfizer

Moderna down 13% premarket after FDA official resigns

31 March

Shares of the biotechnology company Moderna Inc. dropped over 13% during Monday's premarket hours following the news that the Food and Drug Administration's (FDA) top vaccine official, Peter Marks, had resigned.According to a Department of Health and Human Services representative on Friday, Marks, who led the FDA's vaccine division, was presented with an ultimatum to either resign or be fired. A source close to the situation informed NBC News...

US attorney allegedly probes tip about Pfizer's vaccine timing

26 March

The United States Attorney's office is investigating a claim by the British pharmaceutical company GSK about the "delayed" announcement of the success of Pfizer's Covid vaccine in 2020, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.According to the report, Pfizer's former employee, Phil Dormitzer, who later became a senior scientist at Pfizer's rival company, GSK, told his colleagues at GSK that Pfizer delayed the...

Trump picks acting CDC director to lead agency

24 March

United States President Donald Trump chose Dr. Susan Monarez as his nominee to lead the Centers for Disease Control and Prevention (CDC). Monarez, who has been serving as the agency's acting director since January, will now face Senate confirmation. "Americans have lost confidence in the CDC due to political bias and disastrous mismanagement," Trump describes Monarez is a "dedicated public servant," adding that Monarez will work closely with "our...

China's VP He meets with Apple's Cook

24 March

Chinese Vice Premier and Central Financial and Economic Affairs Commission Office Director He Lifeng met with the heads of various major companies from North America to discuss the trade relations between Beijing and the United States, the Asian country's Commerce Ministry (MOFCOM) said in a statement issued on Monday.He met with the leaders of Pfizer Inc., Brookfield Corporation, Mastercard Inc., Cargill Incorporated, Corning Inc., and Apple Inc., with the...

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.